Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.
about
The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System TumorsExpression and regulation of prostate apoptosis response-4 (Par-4) in human glioma stem cells in drug-induced apoptosisMulti-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesGRIM-19 Expression and Function in Human Gliomas.Superoxide mediates direct current electric field-induced directional migration of glioma cells through the activation of AKT and ERK.Treatment results of glioblastoma during the last 30 years in a single instituteImproving thermal stability and efficacy of BCNU in treating glioma cells using PAA-functionalized graphene oxidePrognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapyMetastatic Brain Neuroendocrine Tumor Originating from the Liver.Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical articleEvaluation of outcome and prognostic factors in patients of glioblastoma multiforme: A single institution experience.Changes in caregiver perceptions over time in response to providing care for a loved one with a primary malignant brain tumor.Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.Temozolomide plus radiotherapy for glioblastoma in a Canadian province: efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation.A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy.The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas.SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to TemozolomideThymidine kinase gene delivery using curcumin loaded peptide micelles as a combination therapy for glioblastoma.The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.Photodynamic therapy boosts anti-glioma immunity in mice: a dependence on the activities of T cells and complement C3.Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent.Prognostic factors for glioblastoma patients--a clinical population-based study.Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort.Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.Diagnostic and prognostic molecular markers in common adult gliomas.Role of Glioblastoma Craniotomy Related to Patient Survival: A 10-Year Survey in a Tertiary Care Hospital in Pakistan.Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients.Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.A feasibility study of a deuterium-deuterium neutron generator-based boron neutron capture therapy system for treatment of brain tumors.Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma.
P2860
Q28087476-0A21082E-5DC1-4114-8DBF-1A8F1054AAC4Q28539708-53F30D50-73AA-4BB3-9624-23499E564EE7Q33862791-6DDB3DF9-3F86-49E5-AFF1-2A5651BA2FE9Q33925544-10152E62-0999-4CC2-8BF2-78E1AE752B8FQ34044498-F8B36E27-1F69-443F-AC84-3D0C14CB3DE4Q34684143-DA84EE8F-F443-467E-9049-0860328B4744Q35869502-6B3BBECE-E103-490C-9073-86FDE17F1C9AQ35972720-F51DA9CE-A223-43CA-824B-1E866F1971C0Q36325441-B12A52AD-F21C-4BB2-B04F-AEEA9852CF6DQ36505881-0B44F0DF-71AA-4405-A91B-90949DBB73B3Q37052309-41A958E2-58AE-4A99-A861-85853437A335Q37254651-99514654-3E6D-4148-A2EA-9D9B39A7E5D1Q37432358-000CE233-9333-42F9-933C-CB386BEB4C19Q37628704-463CA335-CE05-4CA0-B3B1-1ED7B630399BQ37953862-82C299EF-CC52-4397-9D7B-40BE0B1ED839Q38081221-F2FD91AB-5AD3-47EA-8F54-547BA5FB6F83Q38262684-033B8131-7D8D-4563-A9DC-584D63E430CCQ38411351-541A16F0-ACBA-41E5-8237-3831C223925AQ38803824-0E5B5107-0D89-4B01-AB68-932A14AA68C7Q38962677-2ADAAF7B-72AD-412C-B4EC-272B448DB43BQ38990450-A6071F6D-B76B-4937-AC58-53D28910191CQ39523557-E7CB0148-1C87-4186-93CE-4A8158F3E8F9Q39712685-5BBA851C-A8A6-4618-AD3A-07C025C691E6Q41377266-D8F57955-1A94-491B-9E48-C2CE2CCC5B33Q43491341-44398B93-F986-4FF3-BC9D-25E2FB9A9036Q44281661-98E03E38-32EB-4DD0-9D92-E24EE1BD3B72Q44387794-8929FEA5-F452-406C-B299-7D24B2E2465DQ47569617-832D109E-FFAE-46FF-9CB2-28E52F022255Q47956458-0910FF0B-E183-4E7A-A187-D80830E94490Q48125202-E65A9294-D278-489E-BC15-9DCCC632797DQ48306394-7B8C5EF4-8E60-41AB-953E-4586C259F434Q48482756-8C9F6433-4009-4F36-B1D8-4F41C97E4315Q48953480-55C1D200-9F45-499D-BA08-001C07D0AB17
P2860
Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Survival of patients with glio ...... d 2004: analysis of 625 cases.
@en
type
label
Survival of patients with glio ...... d 2004: analysis of 625 cases.
@en
prefLabel
Survival of patients with glio ...... d 2004: analysis of 625 cases.
@en
P2093
P2860
P1476
Survival of patients with glio ...... nd 2004: analysis of 625 cases
@en
P2093
P2860
P304
P356
10.1080/02688690701449251
P577
2007-10-01T00:00:00Z